Water Extract ofDryopteris crassirhizomaAttenuates Bone Loss by Suppressing Osteoclast Differentiation and Function
Open Access
- 1 January 2013
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2013, 1-10
Abstract
The rhizome ofDryopteris crassirhizomahas been used as a traditional herbal medicine for treating various inflammatory and infectious diseases such as tapeworm infestation and mumps. In the present study, we investigated the bone protective effect of water extract of the rhizome ofDryopteris crassirhizoma(WEDC). We found that WEDC inhibits osteoclast differentiation via directly acting on osteoclast precursors. In osteoclast precursors, WEDC inhibited receptor activator of nuclear factor-κB ligand- (RANKL-) induced expression of c-Fos and nuclear factor of activated T cells cytoplasmic 1, a key downstream target of c-Fos during osteoclast differentiation. We found that WEDC inhibits RNAKL-induced activation of extracellular-regulated kinase and NF-κB that mediates c-Fos expression and osteoclast differentiation. In addition to the inhibitory effect of osteoclast differentiation, WEDC markedly suppressed bon-resorbing activity of mature osteoclasts, which was accompanied by disruption of actin ring structure. Furthermore, administration of WEDC suppressed RANKL-induced trabecular bone loss in mice. Collectively, our results demonstrate that WEDC inhibits not only osteoclast differentiation by inhibiting RANK signaling pathways in osteoclast precursors but also bone resorption by disrupting actin ring in mature osteoclasts, thereby contributing to its protective effect on bone loss.Keywords
Funding Information
- Korea Institute of Oriental Medicine (K13050)
This publication has 29 references indexed in Scilit:
- NF-κB, the first quarter-century: remarkable progress and outstanding questionsGenes & Development, 2012
- Dryopteris crassirhizoma has anti-cancer effects through both extrinsic and intrinsic apoptotic pathways and G0/G1 phase arrest in human prostate cancer cellsJournal of Ethnopharmacology, 2010
- Evaluation of Pharmaceuticals With a Novel 50-Hour Animal Model of Bone LossJournal of Bone and Mineral Research, 2009
- TRAF6 Autoubiquitination-Independent Activation of the NFκB and MAPK Pathways in Response to IL-1 and RANKLPLOS ONE, 2008
- Two New Triterpenes from the Rhizome of Dryopteris crassirhizoma, and Inhibitory Activities of Its Constituents on Human Immunodeficiency Virus-1 ProteaseChemical and Pharmaceutical Bulletin, 2008
- Osteoclasts; culprits in inflammatory osteolysisArthritis Research & Therapy, 2005
- IKKβ Plays an Essential Role in the Phosphorylation of RelA/p65 on Serine 536 Induced by LipopolysaccharideThe Journal of Immunology, 2003
- Osteoclast differentiation and activationNature, 2003
- Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of OsteoclastsDevelopmental Cell, 2002
- Osteopetrosis in mice lacking NF-κB1 and NF-κB2Nature Medicine, 1997